相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Role of chemotherapy for advanced/recurrent gastric cancer: An individual-patient-data meta-analysis
Koji Oba et al.
EUROPEAN JOURNAL OF CANCER (2013)
Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data
Audrey Mauguen et al.
LANCET ONCOLOGY (2013)
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2012)
Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer
Mitsuru Sasako et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer A Meta-analysis
Xavier Paoletti et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Evaluation of tumor response, disease control, progression-free survival, and time to progression as potential surrogate end points in metastatic breast cancer
Tomasz Burzykowski et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Adjuvant chemotherapy in completely resected gastric cancer: A Randomized phase III trial conducted by GOIRC
Francesco Di Costanzo et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Individual- and trial-level surrogacy in colorectal cancer
Marc Buyse et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2008)
Randomized controlled trial of adjuvant uracil-tegafur versus surgery alone for serosa-negative, locally advanced gastric cancer
T. Nakajima et al.
BRITISH JOURNAL OF SURGERY (2007)
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study)
F. De Vita et al.
ANNALS OF ONCOLOGY (2007)
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Surrogate threshold effect: An alternative measure for meta-analytic surrogate endpoint validation
Tomasz Burzykowski et al.
PHARMACEUTICAL STATISTICS (2006)
Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG
D Nitti et al.
ANNALS OF ONCOLOGY (2006)
Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: Individual patient data from 20,898 patients on 18 randomized trials
DJ Sargent et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer:: 7-year results of the FFCD randomized phase III trial (8801)
O Bouché et al.
ANNALS OF ONCOLOGY (2005)
Randomized trial of adjuvant chemotherapy with mitomycin, fluorouracil, and cytosine arabinoside followed by oral fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1
A Nashimoto et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Adjuvant chemotherapy in gastric cancer: 5-year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group
E Bajetta et al.
ANNALS OF ONCOLOGY (2002)
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.
JS Macdonald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Validation of surrogate end points in multiple randomized clinical trials with failure time end points
T Burzykowski et al.
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS (2001)
分享论文
